Drug that stops metastatic breast cancer also works in previous stages

The breakthrough drug trastuzumab deruxtecan (T-DXd), an antibody chemotherapy that releases the drug inside the cancer cell and considered by some oncologists to be the most active drug against breast cancer to date, has proven effective against new stages of the disease. . The DESTINY-6 study found that the so-called “Trojan horse” was more effective than conventional chemotherapy in patients with metastatic hormonal breast cancer, especially those with hormone receptor positive (RH+) and low HER2 protein levels, who had been previously treated. with endocrine therapy, but not with chemotherapy.